Do you need a District of Columbia Crestor attorney? Contact one of our District of Columbia Crestor attorneys now.
Home : Unsafe Drugs : Crestor : MSN Newsfeeds
Crestor - MSN Newsfeeds
- Bloomberg - Jan. 19 (Bloomberg) -- Complaints to the U.K.'s broadcasting regulator Ofcom about alleged racism against a contestant on the reality television program ``Celebrity Big Brother'' set a third day of records, rising to 38,000. Carphone Warehouse Group ...
- Phramalive.com - Crestor (rosuvastatin), a statin indicated to treat dyslipidaemia, which has posted strong year-on-year growth since its launch in 2003 in spite of safety concerns raised in the US. In 2005, Seroquel (quetiapine), an atypical anti-psychotic used to ...
- Forbes - ... now, cholesterol-lowering drugs like Lipitor from Pfizer (nyse: PFE - news - people ), Vytorin from Merck (nyse: MRK - news - people ) and Schering-Plough (nyse: SGP - news - people ), or Crestor ...
- Forbes - ... now, cholesterol-lowering drugs like Lipitor from Pfizer (nyse: PFE - news - people ), Vytorin from Merck (nyse: MRK - news - people ) and Schering-Plough (nyse: SGP - news - people ), or Crestor ...
- Hartford Courant - Crestor, a drug that lowers cholesterol, also advertises because people with diabetes are more prone to heart disease, obesity, kidney disease, retinal problems and a long list of other ailments. Steinberg isn't shy about disclosing his marketing ...
- European Society of Cardiology - To answer this question, a large-scale (15.000 men and women), randomized clinical trial Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) – will evaluate the effects of statin ...
- Boston Globe - AstraZeneca's Crestor product, for example, has already demonstrated promise in reducing the buildup of fatty plaques in arteries. Better targeting patients for the cholesterol-lowering drug could drive short-term sales of existing therapy, filling ...
- Boston Globe - AstraZeneca's Crestor product, for example, has already demonstrated promise in reducing the buildup of fatty plaques in arteries. Better targeting patients for the cholesterol-lowering drug could drive short-term sales of existing therapy, filling ...
- The Washington Times - Crestor and Lipitor are among the popular drugs unavailable through the VA. Covance found 26 drugs Medicare covers that VANF excludes. These drugs accounted for 264 million prescriptions in 2004. Beyond the reach of VA patients, these drugs ...
- Brandweek - AstraZeneca’s Crestor burned through $128 million, a 15% increase on last year, likely in an attempt to raise its profile to fight off Merck’s rival Zocor, which went generic this year and became much cheaper than the name brands. And Pfizer’s ...
- HealthCentral.com - ... greater reductions in LDL and CRP levels, and that the more that statins can lower LDL, the more effective they are in reducing the progression of atherosclerosis. An important 2006 study found that aggressive treatment with rosuvastatin (Crestor):
- Xagena Medical News - Atorvastatin ( Lipitor ) or Rosuvastatin ( Crestor ), rather than the first generation types, Pravastatin ( Pravachol ), Fluvastatin ( Lescol ) or Simvastatin ( Zocor ). Higher doses of first generation statins were being prescribed, but increasing ...
- Chicago Tribune - Many European experts now believe beta blockers should not be first-choice treatments for hypertension (Lancet, Oct. 29, 2005). Statin-type cholesterol drugs (Crestor, Lipitor, Pravachol, Zocor) sometimes cause aches and pain in muscles and joints ...
- Nine MSN - Pfizer's Lipitor, Merck's Zocor and AstraZeneca's Crestor are among the leading statin drugs on the market. The drugs are effective if taken properly, but some people may be taking doses that are too low or have stopped treatment. The Dutch study of ...
- SAWF News Connect - ... among patients consistently taking the drugs over the whole two-year period at persistently high or intermediate equipotent doses, these patients were also relatively more likely to be using second generation statins i.e. atorvastatin or rosuvastatin ...
- Pharmaceutical Business Review - Benchmark Shionogi's performance against key rivals in the ethical pharmaceutical sector See how the company will benefit from the influx of Crestor royalties from AstraZeneca's international sales Assess the impact of the expiry of key infectious ...
- MSNBC - ... is a risk factor for heart disease, one of the biggest killers in Western countries. Statins lower cholesterol by inhibiting an enzyme that controls how much is produced in the body. Pfizer’s Lipitor, Merck’s Zocor and AstraZeneca’s Crestor are ...
- Bloomberg - ... that the greatest reduction in heart disease -- as observed in patients taking the medicine consistently and at high doses -- was in patients on so-called ``second generation'' statins, including Pfizer Inc.'s Lipitor and AstraZeneca Plc's Crestor ...
- Detroit Free Press - AstraZeneca's Crestor is the most potent drug to cut bad cholesterol. Abbott is purchasing Kos Pharmaceuticals Inc . to obtain its Niaspan drug, the most effective way to raise good cholesterol. The companies also are working together on cholesterol ...
- Seattle Post Intelligencer - AstraZeneca's Crestor is the most potent drug to cut bad cholesterol. Abbott is buying Kos Pharmaceuticals Inc. to obtain its drug Niaspan, the most effective way to raise good cholesterol. The companies are working together on cholesterol drug ...
Do you need a District of Columbia Crestor attorney? Contact one of our District of Columbia Crestor attorneys now.
Pages: Previous ... 4 5 6 7 8 9 10 11 12 13 14 ... Next
